Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 303 (LINC00303) is a non-protein coding gene located on chromosome 1 (1q32.1), denoted by several aliases including C1orf157, NCRNA00303, and FLJ40343. It is classified as a long non-coding RNA (lncRNA), meaning it is a transcript longer than 200 nucleotides that does not encode a protein. LINC00303 has no demonstrated role as a therapeutic or diagnostic target, nor does current literature describe clear biological functions, associations with human pathology, or molecular interactions. No drug interactions, disease links, or established mechanisms of action have been reported for LINC00303 to date. Key facts: - LINC00303 is not a receptor, enzyme, transporter, or classical therapeutic target, nor does it have a reported function in major pathways as of available sources. - It should not be confused with similarly named lncRNAs that have been implicated in cancer or other diseases (such as LINC01503). - The current scientific record provides only basic gene and transcript information, with no functional or clinical annotation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 303 (LINC00303).